SIRT1 VLDlr

Mona Peyman1,2,3,4, Anna Babin-Ebell1,2,3,4, Rosalía Rodríguez-Rodríguez5,6

  • 1Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, Barcelona, Spain.

概括

赛尔图因1 (SIRT1) 激活通过降低非常低密度脂蛋白受体 (VLDLR) 水平来减少脂肪肝. 这项研究揭示了SIRT1.